Search or choose
Find the right test or package.
t(14;20)(q32;q12) IGH/MAFB
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately improving pati...
DiagnosticsLab test
Know more about this test
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately impr...
Understanding t(14;20)(q32;q12) IGH/MAFB
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately improving patient management and care.
What does t(14;20)(q32;q12) IGH/MAFB measure?
This test detects the presence/absence of translocation (14;20) which is a marker for Myeloma. Identifying this abnormality helps guide treatment decisions, predict patient outcomes, and customize therapy for individuals with Myeloma, ultimately improving patient management and care.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.